Concepedia

Andrés Pastor Fernández

AP

Statistics

Publications

4

Citations

152

H-Index

4

Active since

2018

Affiliations

Instituto de Salud Carlos III(Current)

Universidad Autónoma de Madrid

IMDEA Food

SARomics Biostructures (Sweden)

Science for Life Laboratory

Andrés Pastor Fernández is an author at Instituto de Salud Carlos III specializing in pharmacology, medicine, and molecular oncology.

ORCID

Publications per year

2018–2023

4

Publications

4

A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

Marcus J.G.W. Ladds, Ingeborg M.M. van Leeuwen, Catherine J. Drummond et al. · Nature Communications · 2018 · 92 citations · Full text

, , +13

Treatment with the senolytics dasatinib/quercetin reduces <scp>SARS‐CoV</scp>‐2‐related mortality in mice

Andrés Pastor Fernández, Antonio Rodríguez Bertos, Arantzazu Sierra‐Ramírez et al. · Aging Cell · 2023 · 29 citations · Full text

, , +10

Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology

Marcus J.G.W. Ladds, Gergana Popova, Andrés Pastor Fernández et al. · Journal of Biological Chemistry · 2020 · 19 citations · Full text

, , +16

Pharmacological and genetic increases in liver NADPH levels ameliorate NASH progression in female mice

Ildefonso Rodríguez‐Ramiro, Andrés Pastor Fernández, José Luis López-Aceituno et al. · Free Radical Biology and Medicine · 2023 · 12 citations · Full text

, , +17

1–4 of 4